289 related articles for article (PubMed ID: 6887461)
1. Antibody response following measles-mumps-rubella vaccine under conditions of customary use.
Brunell PA; Weigle K; Murphy MD; Shehab Z; Cobb E
JAMA; 1983 Sep; 250(11):1409-12. PubMed ID: 6887461
[TBL] [Abstract][Full Text] [Related]
2. [Experience with preventive measles, mumps and rubella vaccination in unified Germany].
Gerike E; Tischer A
Gesundheitswesen; 1993 Jan; 55(1):38-9. PubMed ID: 8435543
[TBL] [Abstract][Full Text] [Related]
3. [Immunity to measles, mumps and rubella in children vaccinated with triple viral vaccine].
Pisón Garcés FJ; Galbe Sánchez-Ventura J; Arcauz Eguren P; Aguirre y Dabán C; Mengual Gil J; Larrad Mur L
Aten Primaria; 1995 Mar; 15(4):235-7. PubMed ID: 7703334
[TBL] [Abstract][Full Text] [Related]
4. Response to measles-mumps-rubella vaccine in children on dialysis.
Schulman SL; Deforest A; Kaiser BA; Polinsky MS; Baluarte HJ
Pediatr Nephrol; 1992 Mar; 6(2):187-9. PubMed ID: 1571219
[TBL] [Abstract][Full Text] [Related]
5. Immune response after primary and re-vaccination with different combined vaccines against measles, mumps, rubella.
Tischer A; Gerike E
Vaccine; 2000 Jan; 18(14):1382-92. PubMed ID: 10618536
[TBL] [Abstract][Full Text] [Related]
6. Reactogenicity and immunogenicity of a new combined measles-mumps-rubella vaccine: results of a multicentre trial. The Cooperative Group for the Study of MMR vaccines.
Crovari P; Gabutti G; Giammanco G; Dentico P; Moiraghi AR; Ponzio F; Soncini R
Vaccine; 2000 Jun; 18(25):2796-803. PubMed ID: 10812221
[TBL] [Abstract][Full Text] [Related]
7. [Field trial with a new human diploid cell vaccine (HDCV) against measles, mumps and rubella].
Just M; Berger R; Glück R; Wegmann A
Schweiz Med Wochenschr; 1985 Nov; 115(48):1727-30. PubMed ID: 4081704
[TBL] [Abstract][Full Text] [Related]
8. [Clinico-immunologic evaluation of a trivalent vaccine against measles, rubella and mumps].
Schettini F; Manzionna MM; De Mattia D; Amendola F; Di Bitonto G
Minerva Pediatr; 1989 Mar; 41(3):117-22. PubMed ID: 2747598
[TBL] [Abstract][Full Text] [Related]
9. Serological evaluation of a measles, mumps, and rubella vaccine.
Robertson CM; Bennett VJ; Jefferson N; Mayon-White RT
Arch Dis Child; 1988 Jun; 63(6):612-6. PubMed ID: 3291787
[TBL] [Abstract][Full Text] [Related]
10. Low mumps antibody levels induced by mumps-measles-rubella vaccinations in type 1 diabetic children.
Hiltunen M; Hyöty H; Leinikki P; Akerblom HK; Tuomilehto J; Vesikari T
Diabet Med; 1994 Dec; 11(10):942-6. PubMed ID: 7895458
[TBL] [Abstract][Full Text] [Related]
11. Age-stratified seroprevalence of measles, mumps and rubella (MMR) virus infections in Switzerland after the introduction of MMR mass vaccination.
Matter L; Germann D; Bally F; Schopfer K
Eur J Epidemiol; 1997 Jan; 13(1):61-6. PubMed ID: 9062781
[TBL] [Abstract][Full Text] [Related]
12. Decreased measles antibody response after measles-mumps-rubella vaccine in infants with colds.
Krober MS; Stracener CE; Bass JW
JAMA; 1991 Apr; 265(16):2095-6. PubMed ID: 2013930
[TBL] [Abstract][Full Text] [Related]
13. [Morbidity, vaccine coverage and immunity against measles, mumps and rubella in a Gallician population from 2 to 5 years old].
Vázquez Fernández E; López Rois F; Vázquez Carrete JA; Gómez Tato B; Alvarez Ares M
An Esp Pediatr; 1987 Jul; 27(1):27-31. PubMed ID: 3662251
[TBL] [Abstract][Full Text] [Related]
14. Immunogenicity and reactogenicity of indigenously produced MMR vaccine.
Bhargava I; Chhaparwal BC; Phadke MA; Irani SF; Chhaparwal D; Dhorje S; Maheshwari CP
Indian Pediatr; 1995 Sep; 32(9):983-8. PubMed ID: 8935261
[TBL] [Abstract][Full Text] [Related]
15. Mass vaccination programme aimed at eradicating measles, mumps and rubella in Sweden: vaccination of schoolchildren.
Böttiger M; Christenson B; Taranger J; Bergman M
Vaccine; 1985 Jun; 3(2):113-6. PubMed ID: 4036269
[TBL] [Abstract][Full Text] [Related]
16. Previous exposure to measles, mumps, and rubella--but not vaccination during adolescence--correlates to the prevalence of pancreatic and thyroid autoantibodies.
Lindberg B; Ahlfors K; Carlsson A; Ericsson UB; Landin-Olsson M; Lernmark A; Ludvigsson J; Sundkvist G; Ivarsson SA
Pediatrics; 1999 Jul; 104(1):e12. PubMed ID: 10390298
[TBL] [Abstract][Full Text] [Related]
17. Measles, mumps, rubella antibody surveillance: pilot study in Grampian, Scotland.
Narayan KM; Moffat MA
Health Bull (Edinb); 1992 Jan; 50(1):47-53. PubMed ID: 1612895
[TBL] [Abstract][Full Text] [Related]
18. Response to early measles-mumps-rubella vaccination in infants with chronic renal failure and/or receiving peritoneal dialysis.
Flynn JT; Frisch K; Kershaw DB; Sedman AB; Bunchman TE
Adv Perit Dial; 1999; 15():269-72. PubMed ID: 10682116
[TBL] [Abstract][Full Text] [Related]
19. [Age-related seroprevalence of measles, mumps and rubella antibodies in 1996].
Zäch K; Nicoara C; Germann D; Matter L
Schweiz Med Wochenschr; 1998 Apr; 128(17):649-57. PubMed ID: 9622837
[TBL] [Abstract][Full Text] [Related]
20. Immune response to measles, mumps & rubella vaccine at 9, 12 & 15 months of age.
Singh R; John TJ; Cherian T; Raghupathy P
Indian J Med Res; 1994 Oct; 100():155-9. PubMed ID: 7851964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
